Global Short-acting Insulin Market Research Report 2025(Status and Outlook)

March 2025 | 127 pages | ID: GBC992E1A971EN
Bosson Research

Abstracts

Report Overview

Short-acting insulin is a type of insulin that is designed to have a rapid onset and relatively short duration of action in the body.It is used to control blood Short-acting insulin is a type of insulin that is designed to have a rapid onset and relatively short duration of action in the body.This type of insulin starts working within about 15 to 30 minutes after injection,and continues to lower blood sugar for approximately 3 to 6 hours.Its primary function is to manage blood sugar levels by facilitating the uptake of glucose into cells.

This report provides a deep insight into the global Short-acting Insulin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Short-acting Insulin Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Short-acting Insulin market in any manner.

Global Short-acting Insulin Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Eli Lilly

Novo Nordisk

Biocon Biologics

Sanofi

Wockhardt

Bayer

Pfizer

BASF

Abbott Laboratories

Tonghua Dongbao Pharmaceutical

Zhuhai United Pharmaceutical

Sinovac Biotech

Wanbang Biopharmaceuticals

HTBT

Market Segmentation (by Type)

Regular Insulin

Biosynthetic Human Insulin

Recombinant Human Insulin

Other

Market Segmentation (by Application)

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

Complications of Diabetes

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Short-acting Insulin Market
• Overview of the regional outlook of the Short-acting Insulin Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Short-acting Insulin Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Short-acting Insulin
1.2 Key Market Segments
  1.2.1 Short-acting Insulin Segment by Type
  1.2.2 Short-acting Insulin Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SHORT-ACTING INSULIN MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SHORT-ACTING INSULIN MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Short-acting Insulin Product Life Cycle
3.3 Global Short-acting Insulin Revenue Market Share by Company (2020-2025)
3.4 Short-acting Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Short-acting Insulin Company Headquarters, Area Served, Product Type
3.6 Short-acting Insulin Market Competitive Situation and Trends
  3.6.1 Short-acting Insulin Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Short-acting Insulin Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 SHORT-ACTING INSULIN VALUE CHAIN ANALYSIS

4.1 Short-acting Insulin Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SHORT-ACTING INSULIN MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Short-acting Insulin Market Porter's Five Forces Analysis

6 SHORT-ACTING INSULIN MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Short-acting Insulin Market Size Market Share by Type (2020-2025)
6.3 Global Short-acting Insulin Market Size Growth Rate by Type (2021-2025)

7 SHORT-ACTING INSULIN MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Short-acting Insulin Market Size (M USD) by Application (2020-2025)
7.3 Global Short-acting Insulin Sales Growth Rate by Application (2020-2025)

8 SHORT-ACTING INSULIN MARKET SEGMENTATION BY REGION

8.1 Global Short-acting Insulin Market Size by Region
  8.1.1 Global Short-acting Insulin Market Size by Region
  8.1.2 Global Short-acting Insulin Market Size Market Share by Region
8.2 North America
  8.2.1 North America Short-acting Insulin Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Short-acting Insulin Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Short-acting Insulin Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Short-acting Insulin Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Short-acting Insulin Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Eli Lilly
  9.1.1 Eli Lilly Basic Information
  9.1.2 Eli Lilly Short-acting Insulin Product Overview
  9.1.3 Eli Lilly Short-acting Insulin Product Market Performance
  9.1.4 Eli Lilly SWOT Analysis
  9.1.5 Eli Lilly Business Overview
  9.1.6 Eli Lilly Recent Developments
9.2 Novo Nordisk
  9.2.1 Novo Nordisk Basic Information
  9.2.2 Novo Nordisk Short-acting Insulin Product Overview
  9.2.3 Novo Nordisk Short-acting Insulin Product Market Performance
  9.2.4 Novo Nordisk SWOT Analysis
  9.2.5 Novo Nordisk Business Overview
  9.2.6 Novo Nordisk Recent Developments
9.3 Biocon Biologics
  9.3.1 Biocon Biologics Basic Information
  9.3.2 Biocon Biologics Short-acting Insulin Product Overview
  9.3.3 Biocon Biologics Short-acting Insulin Product Market Performance
  9.3.4 Biocon Biologics SWOT Analysis
  9.3.5 Biocon Biologics Business Overview
  9.3.6 Biocon Biologics Recent Developments
9.4 Sanofi
  9.4.1 Sanofi Basic Information
  9.4.2 Sanofi Short-acting Insulin Product Overview
  9.4.3 Sanofi Short-acting Insulin Product Market Performance
  9.4.4 Sanofi Business Overview
  9.4.5 Sanofi Recent Developments
9.5 Wockhardt
  9.5.1 Wockhardt Basic Information
  9.5.2 Wockhardt Short-acting Insulin Product Overview
  9.5.3 Wockhardt Short-acting Insulin Product Market Performance
  9.5.4 Wockhardt Business Overview
  9.5.5 Wockhardt Recent Developments
9.6 Bayer
  9.6.1 Bayer Basic Information
  9.6.2 Bayer Short-acting Insulin Product Overview
  9.6.3 Bayer Short-acting Insulin Product Market Performance
  9.6.4 Bayer Business Overview
  9.6.5 Bayer Recent Developments
9.7 Pfizer
  9.7.1 Pfizer Basic Information
  9.7.2 Pfizer Short-acting Insulin Product Overview
  9.7.3 Pfizer Short-acting Insulin Product Market Performance
  9.7.4 Pfizer Business Overview
  9.7.5 Pfizer Recent Developments
9.8 BASF
  9.8.1 BASF Basic Information
  9.8.2 BASF Short-acting Insulin Product Overview
  9.8.3 BASF Short-acting Insulin Product Market Performance
  9.8.4 BASF Business Overview
  9.8.5 BASF Recent Developments
9.9 Abbott Laboratories
  9.9.1 Abbott Laboratories Basic Information
  9.9.2 Abbott Laboratories Short-acting Insulin Product Overview
  9.9.3 Abbott Laboratories Short-acting Insulin Product Market Performance
  9.9.4 Abbott Laboratories Business Overview
  9.9.5 Abbott Laboratories Recent Developments
9.10 Tonghua Dongbao Pharmaceutical
  9.10.1 Tonghua Dongbao Pharmaceutical Basic Information
  9.10.2 Tonghua Dongbao Pharmaceutical Short-acting Insulin Product Overview
  9.10.3 Tonghua Dongbao Pharmaceutical Short-acting Insulin Product Market Performance
  9.10.4 Tonghua Dongbao Pharmaceutical Business Overview
  9.10.5 Tonghua Dongbao Pharmaceutical Recent Developments
9.11 Zhuhai United Pharmaceutical
  9.11.1 Zhuhai United Pharmaceutical Basic Information
  9.11.2 Zhuhai United Pharmaceutical Short-acting Insulin Product Overview
  9.11.3 Zhuhai United Pharmaceutical Short-acting Insulin Product Market Performance
  9.11.4 Zhuhai United Pharmaceutical Business Overview
  9.11.5 Zhuhai United Pharmaceutical Recent Developments
9.12 Sinovac Biotech
  9.12.1 Sinovac Biotech Basic Information
  9.12.2 Sinovac Biotech Short-acting Insulin Product Overview
  9.12.3 Sinovac Biotech Short-acting Insulin Product Market Performance
  9.12.4 Sinovac Biotech Business Overview
  9.12.5 Sinovac Biotech Recent Developments
9.13 Wanbang Biopharmaceuticals
  9.13.1 Wanbang Biopharmaceuticals Basic Information
  9.13.2 Wanbang Biopharmaceuticals Short-acting Insulin Product Overview
  9.13.3 Wanbang Biopharmaceuticals Short-acting Insulin Product Market Performance
  9.13.4 Wanbang Biopharmaceuticals Business Overview
  9.13.5 Wanbang Biopharmaceuticals Recent Developments
9.14 HTBT
  9.14.1 HTBT Basic Information
  9.14.2 HTBT Short-acting Insulin Product Overview
  9.14.3 HTBT Short-acting Insulin Product Market Performance
  9.14.4 HTBT Business Overview
  9.14.5 HTBT Recent Developments

10 SHORT-ACTING INSULIN MARKET FORECAST BY REGION

10.1 Global Short-acting Insulin Market Size Forecast
10.2 Global Short-acting Insulin Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Short-acting Insulin Market Size Forecast by Country
  10.2.3 Asia Pacific Short-acting Insulin Market Size Forecast by Region
  10.2.4 South America Short-acting Insulin Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Short-acting Insulin by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

11.1 Global Short-acting Insulin Market Forecast by Type (2026-2033)
11.2 Global Short-acting Insulin Market Forecast by Application (2026-2033)

12 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Short-acting Insulin Market Size Comparison by Region (M USD)
Table 5. Global Short-acting Insulin Revenue (M USD) by Company (2020-2025)
Table 6. Global Short-acting Insulin Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short-acting Insulin as of 2024)
Table 8. Short-acting Insulin Company Headquarters and Area Served
Table 9. Company Short-acting Insulin Product Type
Table 10. Global Short-acting Insulin Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Short-acting Insulin Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Short-acting Insulin Market Size by Type (M USD)
Table 21. Global Short-acting Insulin Market Size (M USD) by Type (2020-2025)
Table 22. Global Short-acting Insulin Market Size Share by Type (2020-2025)
Table 23. Global Short-acting Insulin Market Size Growth Rate by Type (2021-2025)
Table 24. Global Short-acting Insulin Market Size by Application
Table 25. Global Short-acting Insulin Market Size by Application (2020-2025) & (M USD)
Table 26. Global Short-acting Insulin Market Share by Application (2020-2025)
Table 27. Global Short-acting Insulin Sales Growth Rate by Application (2020-2025)
Table 28. Global Short-acting Insulin Market Size by Region (2020-2025) & (M USD)
Table 29. Global Short-acting Insulin Market Size Market Share by Region (2020-2025)
Table 30. North America Short-acting Insulin Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Short-acting Insulin Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Short-acting Insulin Market Size by Region (2020-2025) & (M USD)
Table 33. South America Short-acting Insulin Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Short-acting Insulin Market Size by Region (2020-2025) & (M USD)
Table 35. Eli Lilly Basic Information
Table 36. Eli Lilly Short-acting Insulin Product Overview
Table 37. Eli Lilly Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Eli Lilly SWOT Analysis
Table 39. Eli Lilly Business Overview
Table 40. Eli Lilly Recent Developments
Table 41. Novo Nordisk Basic Information
Table 42. Novo Nordisk Short-acting Insulin Product Overview
Table 43. Novo Nordisk Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Novo Nordisk SWOT Analysis
Table 45. Novo Nordisk Business Overview
Table 46. Novo Nordisk Recent Developments
Table 47. Biocon Biologics Basic Information
Table 48. Biocon Biologics Short-acting Insulin Product Overview
Table 49. Biocon Biologics Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Biocon Biologics SWOT Analysis
Table 51. Biocon Biologics Business Overview
Table 52. Biocon Biologics Recent Developments
Table 53. Sanofi Basic Information
Table 54. Sanofi Short-acting Insulin Product Overview
Table 55. Sanofi Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Sanofi Business Overview
Table 57. Sanofi Recent Developments
Table 58. Wockhardt Basic Information
Table 59. Wockhardt Short-acting Insulin Product Overview
Table 60. Wockhardt Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Wockhardt Business Overview
Table 62. Wockhardt Recent Developments
Table 63. Bayer Basic Information
Table 64. Bayer Short-acting Insulin Product Overview
Table 65. Bayer Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Bayer Business Overview
Table 67. Bayer Recent Developments
Table 68. Pfizer Basic Information
Table 69. Pfizer Short-acting Insulin Product Overview
Table 70. Pfizer Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Pfizer Business Overview
Table 72. Pfizer Recent Developments
Table 73. BASF Basic Information
Table 74. BASF Short-acting Insulin Product Overview
Table 75. BASF Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 76. BASF Business Overview
Table 77. BASF Recent Developments
Table 78. Abbott Laboratories Basic Information
Table 79. Abbott Laboratories Short-acting Insulin Product Overview
Table 80. Abbott Laboratories Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Recent Developments
Table 83. Tonghua Dongbao Pharmaceutical Basic Information
Table 84. Tonghua Dongbao Pharmaceutical Short-acting Insulin Product Overview
Table 85. Tonghua Dongbao Pharmaceutical Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Tonghua Dongbao Pharmaceutical Business Overview
Table 87. Tonghua Dongbao Pharmaceutical Recent Developments
Table 88. Zhuhai United Pharmaceutical Basic Information
Table 89. Zhuhai United Pharmaceutical Short-acting Insulin Product Overview
Table 90. Zhuhai United Pharmaceutical Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Zhuhai United Pharmaceutical Business Overview
Table 92. Zhuhai United Pharmaceutical Recent Developments
Table 93. Sinovac Biotech Basic Information
Table 94. Sinovac Biotech Short-acting Insulin Product Overview
Table 95. Sinovac Biotech Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Sinovac Biotech Business Overview
Table 97. Sinovac Biotech Recent Developments
Table 98. Wanbang Biopharmaceuticals Basic Information
Table 99. Wanbang Biopharmaceuticals Short-acting Insulin Product Overview
Table 100. Wanbang Biopharmaceuticals Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Wanbang Biopharmaceuticals Business Overview
Table 102. Wanbang Biopharmaceuticals Recent Developments
Table 103. HTBT Basic Information
Table 104. HTBT Short-acting Insulin Product Overview
Table 105. HTBT Short-acting Insulin Revenue (M USD) and Gross Margin (2020-2025)
Table 106. HTBT Business Overview
Table 107. HTBT Recent Developments
Table 108. Global Short-acting Insulin Market Size Forecast by Region (2026-2033) & (M USD)
Table 109. North America Short-acting Insulin Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Europe Short-acting Insulin Market Size Forecast by Country (2026-2033) & (M USD)
Table 111. Asia Pacific Short-acting Insulin Market Size Forecast by Region (2026-2033) & (M USD)
Table 112. South America Short-acting Insulin Market Size Forecast by Country (2026-2033) & (M USD)
Table 113. Middle East and Africa Short-acting Insulin Market Size Forecast by Country (2026-2033) & (M USD)
Table 114. Global Short-acting Insulin Market Size Forecast by Type (2026-2033) & (M USD)
Table 115. Global Short-acting Insulin Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Industry Chain of Short-acting Insulin
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Short-acting Insulin Market Size (M USD), 2024-2033
Figure 5. Global Short-acting Insulin Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Short-acting Insulin Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Short-acting Insulin Product Life Cycle
Figure 12. Global Short-acting Insulin Revenue Share by Company in 2024
Figure 13. Short-acting Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Short-acting Insulin Revenue in 2024
Figure 15. Value Chain Map of Short-acting Insulin
Figure 16. Global Short-acting Insulin Market PEST Analysis
Figure 17. Global Short-acting Insulin Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Short-acting Insulin Market Share by Type
Figure 20. Market Size Share of Short-acting Insulin by Type (2020-2025)
Figure 21. Market Size Share of Short-acting Insulin by Type in 2024
Figure 22. Global Short-acting Insulin Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Short-acting Insulin Market Share by Application
Figure 25. Global Short-acting Insulin Market Share by Application (2020-2025)
Figure 26. Global Short-acting Insulin Market Share by Application in 2024
Figure 27. Global Short-acting Insulin Sales Growth Rate by Application (2020-2025)
Figure 28. Global Short-acting Insulin Market Size Market Share by Region (2020-2025)
Figure 29. North America Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Short-acting Insulin Market Size Market Share by Country in 2024
Figure 31. U.S. Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Short-acting Insulin Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Short-acting Insulin Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Short-acting Insulin Market Share by Country in 2024
Figure 36. Germany Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Short-acting Insulin Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Short-acting Insulin Market Size Market Share by Region in 2024
Figure 43. China Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Short-acting Insulin Market Size and Growth Rate (M USD)
Figure 49. South America Short-acting Insulin Market Size Market Share by Country in 2024
Figure 50. Brazil Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Short-acting Insulin Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Short-acting Insulin Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Short-acting Insulin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Short-acting Insulin Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Short-acting Insulin Market Share Forecast by Type (2026-2033)
Figure 62. Global Short-acting Insulin Market Share Forecast by Application (2026-2033)